Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anjali Rohatgi

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cancer|December 11, 2024
Improving survival for patients with metastatic non-small cell lung cancer in the immunotherapy eraDavid Zhang, Anjali Rohatgi
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2026
Lorlatinib: The Crown Jewel of ALK InhibitorsAnjali Rohatgi, Ramaswamy Govindan
Lung Cancer (Amsterdam, Netherlands)|January 23, 2022
Targeting KRAS G12C mutation in lung adenocarcinomaAnjali Rohatgi, Ramaswamy Govindan
Frontiers in Oncology|March 18, 2021
Beyond PD-1: The Next Frontier for Immunotherapy in MelanomaAnjali Rohatgi, John M Kirkwood
Nature Reviews. Clinical Oncology|September 26, 2020
Cancer vaccine induces potent T cell responses - but is it enough?Anjali Rohatgi, John M Kirkwood
Cancer|February 17, 2026
Neoadjuvant therapy for patients with nonsmall cell lung cancer: Not as easy in the real worldGiordano Fabricio Cittolin-Santos, Anjali Rohatgi
Clinical Chemistry|March 4, 2025
A Pulmonary Nodule with an Unexpected Mutation ProfileLulu Sun, Hannah R Krigman, Anjali Rohatgi, et al.
Journal of Molecular Recognition : JMR|February 24, 2009
Scoring ligand similarity in structure-based virtual screeningMaria I Zavodszky, Anjali Rohatgi, Jeffrey R Van Voorst, et al.
Journal of Virology|December 17, 2013
Infection of myofibers contributes to increased pathogenicity during infection with an epidemic strain of chikungunya virusAnjali Rohatgi, Joseph C Corbo, Kristen Monte, et al.
Plos Pathogens|October 27, 2011
ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugationScott W Werneke, Clementine Schilte, Anjali Rohatgi, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer|December 11, 2024
Improving survival for patients with metastatic non-small cell lung cancer in the immunotherapy eraDavid Zhang, Anjali Rohatgi
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2026
Lorlatinib: The Crown Jewel of ALK InhibitorsAnjali Rohatgi, Ramaswamy Govindan
Lung Cancer (Amsterdam, Netherlands)|January 23, 2022
Targeting KRAS G12C mutation in lung adenocarcinomaAnjali Rohatgi, Ramaswamy Govindan
Frontiers in Oncology|March 18, 2021
Beyond PD-1: The Next Frontier for Immunotherapy in MelanomaAnjali Rohatgi, John M Kirkwood
Nature Reviews. Clinical Oncology|September 26, 2020
Cancer vaccine induces potent T cell responses - but is it enough?Anjali Rohatgi, John M Kirkwood
Cancer|February 17, 2026
Neoadjuvant therapy for patients with nonsmall cell lung cancer: Not as easy in the real worldGiordano Fabricio Cittolin-Santos, Anjali Rohatgi
Clinical Chemistry|March 4, 2025
A Pulmonary Nodule with an Unexpected Mutation ProfileLulu Sun, Hannah R Krigman, Anjali Rohatgi, et al.
Journal of Molecular Recognition : JMR|February 24, 2009
Scoring ligand similarity in structure-based virtual screeningMaria I Zavodszky, Anjali Rohatgi, Jeffrey R Van Voorst, et al.
Journal of Virology|December 17, 2013
Infection of myofibers contributes to increased pathogenicity during infection with an epidemic strain of chikungunya virusAnjali Rohatgi, Joseph C Corbo, Kristen Monte, et al.
Plos Pathogens|October 27, 2011
ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugationScott W Werneke, Clementine Schilte, Anjali Rohatgi, et al.
Pageof 2